HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit

Featuring perspectives from Dr Aditya Bardia, Dr Virginia F Borges, Dr Harold J Burstein and Dr Joyce O'Shaughnessy, including the following topics:

• Introduction (0:00)
• HER2-Positive Breast Cancer — Dr O'Shaughnessy (3:13)
• Triple-Negative Breast Cancer — Dr Bardia (32:56)
• Personalizing Adjuvant Therapy for Patients with HR-Positive Breast Cancer — Dr Borges (57:35)
• Current Role of CDK4/6 Inhibitors in the Localized Setting — Dr Burstein (1:25:15)

CME information and select publications